These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7746283)

  • 1. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
    Bai R; Taylor GF; Schmidt JM; Williams MD; Kepler JA; Pettit GR; Hamel E
    Mol Pharmacol; 1995 May; 47(5):965-76. PubMed ID: 7746283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
    Bai R; Schwartz RE; Kepler JA; Pettit GR; Hamel E
    Cancer Res; 1996 Oct; 56(19):4398-406. PubMed ID: 8813133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
    Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
    Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
    Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
    Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
    Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
    Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
    Bai R; Pettit GR; Hamel E
    Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
    Bai RL; Pettit GR; Hamel E
    J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
    Bai R; Durso NA; Sackett DL; Hamel E
    Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin.
    Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM
    Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
    Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct photoaffinity labeling by dolastatin 10 of the amino-terminal peptide of beta-tubulin containing cysteine 12.
    Bai R; Covell DG; Taylor GF; Kepler JA; Copeland TD; Nguyen NY; Pettit GR; Hamel E
    J Biol Chem; 2004 Jul; 279(29):30731-40. PubMed ID: 15123603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of ustiloxin A with bovine brain tubulin.
    Ludueńa RF; Roach MC; Prasad V; Banerjee M; Koiso Y; Li Y; Iwasaki S
    Biochem Pharmacol; 1994 Apr; 47(9):1593-9. PubMed ID: 8185673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
    Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
    Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity.
    Verdier-Pinard P; Kepler JA; Pettit GR; Hamel E
    Mol Pharmacol; 2000 Jan; 57(1):180-7. PubMed ID: 10617693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.
    Hamel E; Lin CM; Flynn E; D'Amato RJ
    Biochemistry; 1996 Jan; 35(4):1304-10. PubMed ID: 8573587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
    Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
    Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
    Bai R; Friedman SJ; Pettit GR; Hamel E
    Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of drug-induced tubulin rings by fluorescence correlation spectroscopy.
    Boukari H; Nossal R; Sackett DL
    Biochemistry; 2003 Feb; 42(5):1292-300. PubMed ID: 12564932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
    Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.